Celecoxib Completed Phase 4 Trials for Ankylosing Spondylitis (AS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02528201A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis